Recent Finacing
Recent Raise
StarkAge Therapeutics develops STX-1, a targeted therapy addressing senescent cells induced by anti-cancer treatments to reduce post-therapy cellular senescence.
Focus Areas
Total Raised
Funding round
See the team members at Starkage Therapeutics.
